Table 3.
Included studies
| Age reported | Country | Sample context | Number | Data collection analysis | |
|---|---|---|---|---|---|
| Beaton [23] | 64 (47–80) | Canada | Fragility fracture: fracture clinic | 24 (18 women) | 5 focus groups, grounded theory |
| Hallrup [24] | 76–86 | Sweden | Fragility fracture: fracture prevention programme | 13 women | In-depth interview, phenomenology |
| Besser [25] | 69 (SD 10.1) | UK | OP/osteopenia and medication: OP screening unit/rheumatology | 14 women | Semi-structured interviews, thematic analysis |
| De-souza [26] | 36–79 | Brazil | OP; calcium disorders unit | 12 (11 women) | Non-structured interviews grounded theory |
| French [27] | 67.4 (52–87) | Canada | Osteopenia (13)/OP (17): OP treatment programme | 30 women | Focus group, thematic analysis |
| Giangregorio [28] | 67.5 (SD 12.7) | Canada | Fragility fracture: fracture clinic | 127 women | Telephone interview, thematic analysis |
| Hallberg [29] | 68–84 | Sweden | Fragility fracture (vertebral): follow-up study | 10 women | Semi-structured interviews, thematic analysis |
| Hansen [30] | 65–79 | Denmark | Fragility fracture (first known): DEXA scan clinic | 15 women | Open interviews, phenomenology |
| Iversen [31] | 65–85 | USA | OP/osteopenia and medication: adverts in hospital newsletter | 32 (30 women) | 3 focus groups, thematic analysis |
| Jachna [32] | 84 (71–93) | USA | OP and fragility fracture (hip): assisted living facility | 5 women | Semi-structured interviews, content analysis |
| Lau [33] | 70 (48–88) | Canada | OP/osteopenia and medication: primary and secondary healthcare professionals | 37 women | 7 focus groups, phenomenology |
| Mazor [34] | 73.4 (SD 6.2) | USA | OP/osteopenia and medication/multi-specialty group practice | 36 women | Telephone interview, thematic analysis |
| Mckenna [35] | 43–82 | UK | OP: support groups; exercise classes and 5 Asian community centres. | 21 women | Semi-structured interviews, phenomenology |
| Meadows [36] | 40–65 | Canada | Fragility fracture: women and bone health study | 19 women | Semi-structured interviews, thematic analysis |
| Meadows [37] | 40–65 | Canada | Fragility fracture: women and bone health study | 24 women | 4 focus group, thematic analysis |
| Nielson [38] | 51–82 | Denmark | OP (men): department of endocrinology | 16 men | 4 focus groups, phenomenology |
| Nielson [39] | 50–84 | UK/Denmark | OP and DEXA scan: OP management or self-help group | 14 (10 women) | Semi-structured interviews, phenomenology |
| Paier [40] | USA | Fragility fracture (vertebral): via healthcare professionals | 5 women | Semi-structured interviews, phenomenology | |
| Quantock [41] | 70 (65–76) | UK | OP (severe): OP service | 11 women | Focus group, thematic analysis |
| Qvist [42] | 68 (60–93) | Sweden | Fragility fracture (vertebral): exercise programme | 11 women | Open interviews, thematic analysis |
| Richardson [43] | 33–81 | UK | DEXA scan: DEXA scan clinic | 15 women | Semi-structured interviews ‘template analysis’ |
| Roberto [44] | 53–89 | USA | OP: community adverts | 21 women | 4 focus groups, thematic analysis |
| Sale [45] | 49–82 | Canada | OP: OP-screening programme | 18 (14 women) | Semi-structured interviews, phenomenology |
| Sale [46] | 47–80 | Canada | Fragility fracture and DEXA scan: OP-screening programme | 24 (18 women) | 5 focus groups, thematic analysis |
| Sale [47] | 65–88 | Canada | Fragility fracture: OP-screening programme | 30 (21 women) | Semi-structured interviews, phenomenology |
| Sale [48] | 50–79 | Canada | Fragility fracture: OP-screening programme | 25 (22 women) | Semi-structured interviews, phenomenology |
| Sale [49] | 65–88 | Canada | Fragility fracture: OP-screening programme | 21 (15 women) | Semi-structured interviews, phenomenology |
| Sale [50] | |||||
| Sale [51] | 51–89 | Canada | Fragility fracture: advert in patient newsletter | 28 (26 females) | Telephone interview, phenomenology |
| Sale [52] | |||||
| Salter [53] | 70–85 | UK | OP and medication: multi-centre trial | 30 women | Semi-structured interviews, thematic analysis |
| Solimeo [54] | 70.36 (53–86) | USA | OP (men): bone health clinic | 23 men | Semi-structured interviews, thematic analysis |
| Weston [55] | 68–79 | UK | OP and medication: OP screening trial | 10 women | Semi-structured interviews, phenomenology |
| Wilkins [56, 57] | 65.3 (54–80) | Canada | OP: OP clinic or self-help group | 28 women | In-depth interview, thematic analysis |